These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration. Woloschuk DM; Wermeling JR; Pruemer JM Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472 [TBL] [Abstract][Full Text] [Related]
5. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration. Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988 [TBL] [Abstract][Full Text] [Related]
6. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration. Inagaki K; Gill MA; Okamoto MP; Takagi J J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498 [TBL] [Abstract][Full Text] [Related]
7. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection. Thompson DF; Stiles ML; Allen LV; Tu YH Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228 [TBL] [Abstract][Full Text] [Related]
8. Stability of ondansetron and fluconazole in 5% dextrose injection and normal saline during Y-site administration. Burm JP Arch Pharm Res; 1997 Apr; 20(2):171-5. PubMed ID: 18975196 [TBL] [Abstract][Full Text] [Related]
9. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration. Inagaki K; Gill MA; Okamoto MP; Takagi J Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644 [TBL] [Abstract][Full Text] [Related]
10. Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Silvestri AP; Mitrano FP; Baptista RJ; Williams DA Am J Hosp Pharm; 1991 Dec; 48(12):2641-3. PubMed ID: 1814209 [TBL] [Abstract][Full Text] [Related]
11. Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection. Belliveau PP; Nightingale CH; Quintiliani R Am J Hosp Pharm; 1994 Apr; 51(7):901-4. PubMed ID: 8017440 [TBL] [Abstract][Full Text] [Related]
12. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration. Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460 [TBL] [Abstract][Full Text] [Related]
13. Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated y-site administration. Inagaki K; Kambara M; Mizuno M; Okuda J; Gill MA; Nishida M Int J Pharm Compd; 1998; 2(4):318-21. PubMed ID: 23989642 [TBL] [Abstract][Full Text] [Related]
14. Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections. Visor GC; Lin LH; Jackson SE; Winterle JS; Lee G; Kenley RA Am J Hosp Pharm; 1986 Nov; 43(11):2810-2. PubMed ID: 3492139 [TBL] [Abstract][Full Text] [Related]
15. Stability of cefotaxime sodium and metronidazole in an i.v. admixture at 8 degrees C. Rivers TE; McBride HA; Trang JM Am J Hosp Pharm; 1991 Dec; 48(12):2638-40. PubMed ID: 1814208 [TBL] [Abstract][Full Text] [Related]